Rocket Lab USA is trading 4% down at $67.19 as investors weigh financing and dilution risks following its recent $8 billion Iridium acquisition.
- The stock is retracing part of its recent sharp rally as the market assesses potential integration challenges and deal-related costs.
- Broader market weakness and sector rotation are contributing to the downward pressure, despite a lack of fresh company-specific news.
- Sentiment remains cautious as traders monitor the long-term impact of the acquisition on the company's capital structure.